Compare · AIKI vs ZONE

AIKI vs ZONE

Side-by-side comparison of AIkido Pharma Inc. (AIKI) and Zone Frontier Inc. (ZONE): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AIKI and ZONE operate in Specialty Chemicals (Consumer Discretionary), so they compete in similar markets.
  • ZONE carries a market cap of $25.5M.
  • ZONE has hit the wire 6 times in the past 4 weeks while AIKI has been quiet.
  • AIKI has more recent analyst coverage (1 ratings vs 0 for ZONE).
MetricAIKIZONE
Company
AIkido Pharma Inc.
Zone Frontier Inc.
Price
-
-
Market cap
-
$25.5M
1M return
-
-46.76%
1Y return
-
-86.71%
Industry
Specialty Chemicals
Specialty Chemicals
Exchange
NASDAQ
AMEX
IPO
2024
News (4w)
0
6
Recent ratings
1
0
AIKI

AIkido Pharma Inc.

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York.

ZONE

Zone Frontier Inc.

Zone Frontier Inc. (NYSE AMERICAN: ZONE) is helping to build the critical infrastructure that powers the AI economy. Through a growing pipeline of projects, the Company aims to help meet the increasing demand for compute capacity, power, and digital infrastructure required by the world's leading AI companies.

Latest AIKI

Latest ZONE